Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:

Wednesday, April 5, 2017

5-Minute Pen & Paper Dementia Test

For your doctor to establish a baseline for you since you likely will get dementia.
1. A documented 33% dementia chance post-stroke from an Australian study   May 2012.
2. Then this study came out and seems to have a range from 17-66%. December 2013.
3. A 20% chance in this research.   July 2013.

Or are these other tests better?

Cantab Mobile Dementia Test Approved by FDA 

This 5-minute test could detect if you are at risk for Alzheimer's disease

Study Shows Effectiveness of Brief, Simple Test to Screen for Cognitive Impairment in AD



5-Minute Pen & Paper Dementia Test
A quick and effective dementia test is available from a leading neuroscientist at Florida Atlantic University. The three to five minute test produces results comparable to "gold standard" dementia tests used by clinicians today. Find out more.

Determining whether or not an individual has dementia and to what degree is a long and laborious process that can take an experienced professional such as a clinician about four to five hours to administer, interpret and score the test results.


The "Quick Dementia Rating System" (QDRS), which uses an evidence-based methodology, validly and reliably differentiates individuals with and without dementia. When dementia is present, it accurately stages the condition to determine if it is very mild, mild, moderate or severe. QDRS has applications for use in clinical practice, to pre-qualify patients in clinical trials, prevention studies, community surveys and biomarker research.

James E. Galvin, M.D., M.P.H., is one of the most prominent neuroscientists in the country and a professor of clinical biomedical science in the Charles E. Schmidt College of Medicine and a professor in the Christine E. Lynn College of Nursing at Florida Atlantic University, and the QDRS is his brainchild. He recently published an article on his findings in Alzheimer's & Dementia, the journal of the Alzheimer's Association. Galvin has developed a number of dementia screening tools including the AD8, a brief informant interview to translate research findings to community settings that is used worldwide to detect dementia in diverse populations.


AD8 is one of the world's easiest and simplest dementia tests. Valid and reliable in differentiating individuals with dementia from those who do not show signs of dementia, it is sensitive to the earliest signs of cognitive change as reported by an informant (such as a caregiver or a nurse). The AD8 has been demonstrated to perform equally as well as a telephone interview as it does during an in-person interview. All told, AD8 is short, simple, quick to administer (~3 minutes) and culturally-sensitive.

Click here for The AD8 Test.


In contrast to the simpler 8-question AD8 test, Dr. Gavin's newer QDRS test is a 10-item questionnaire that can be completed by a caregiver, friend or family member, and is brief enough to be printed on one page or viewed as a single screenshot, maximizing its clinical utility. Scores range from 0 to 30 with higher scores representing greater cognitive impairment. The questionnaire covers: 1) memory and recall; 2) orientation; 3) decision-making and problem-solving abilities; 4) activities outside the home; 5) function at home and hobbies; 6) toileting and personal hygiene; 7) behavior and personality changes; 8) language and communication abilities; 9) mood; and 10) attention and concentration.

The total score is derived by summing up the 10 fields and each area has five possible answers increasing in severity of symptoms. The 10 areas capture the prominent symptoms of mild cognitive impairment, Alzheimer's disease, and non-Alzheimer's neurocognitive disorders including Lewy Body Dementia, frontotemporal degeneration, vascular dementia, chronic traumatic encephalopathy and depression.

Click here for The QDRS Test. (Quick Dementia Rating System)

No comments:

Post a Comment